|
Market Closed -
Xetra
19:35:29 14/08/2026 +04
|
After hours 20:18:36 | |||
| 4.780 EUR | +1.70% |
|
4.700 | -1.67% |
| Market Cap | 223M 258M 210M 191M 359M 24.72B 365M 2.46B 961M 12.38B 970M 949M 41.13B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 223M 258M 210M 191M 359M 24.72B 365M 2.46B 961M 12.38B 970M 949M 41.13B | EV / Sales 2026 * |
0.28x | EV / Sales 2027 * | 0.28x |
| Free-Float |
12.27% | Yield 2026 * |
0.85% | Yield 2027 * | 0.85% |
| 1 day | +1.70% | ||
| 1 week | +11.16% | ||
| Current month | +16.02% | ||
| 1 month | +16.59% | ||
| 3 months | +32.04% | ||
| 6 months | +29.19% | ||
| Current year | +29.19% |
| 1 week | 4.36 | 4.78 | |
| 1 month | 4.04 | 4.78 | |
| Current year | 3.22 | 4.78 | |
| 1 year | 2.88 | 4.78 | |
| 3 years | 2.28 | 4.78 | |
| 5 years | 2.28 | 4.78 | |
| 10 years | 2.28 | 6.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tino Marco Fritz
CEO | Chief Executive Officer | 50 | - |
Nicola Bertrand
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2024 |
Martin Buse
CMP | Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Hans Hilpert
BRD | Director/Board Member | 60 | 01/01/2003 |
Michael Bock
BRD | Director/Board Member | 63 | 25/05/2005 |
| Director/Board Member | 63 | 20/09/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.70% | +11.16% | +55.19% | +62.59% | 258M | ||
| -0.85% | -1.56% | +18.67% | +37.12% | 17.88B | ||
| +3.73% | -0.60% | +14.24% | +81.82% | 12.96B | ||
| +0.11% | -1.31% | +3.30% | +72.11% | 12.19B | ||
| -0.57% | -0.23% | -33.10% | -53.10% | 12.04B | ||
| -0.27% | -0.72% | +9.43% | +84.79% | 10.51B | ||
| +1.68% | +8.68% | - | - | 9.58B | ||
| -0.51% | -2.01% | -14.85% | -32.17% | 9.39B | ||
| -0.13% | +1.15% | +15.51% | -21.79% | 7.29B | ||
| +2.52% | +0.98% | -1.78% | +192.18% | 7.17B | ||
| Average | +0.74% | +0.53% | +7.40% | +47.06% | 9.93B | |
| Weighted average by Cap. | +0.54% | -0.87% | +2.61% | +42.24% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 787M 912M 740M 673M 1.27B 87.18B 1.29B 8.67B 3.39B 43.66B 3.42B 3.35B 145B | 803M 930M 755M 686M 1.29B 88.93B 1.31B 8.84B 3.46B 44.53B 3.49B 3.42B 148B |
| Net income | 36.66M 42.45M 34.45M 31.33M 58.91M 4.06B 59.88M 404M 158M 2.03B 159M 156M 6.75B | 38.2M 44.22M 35.89M 32.64M 61.37M 4.23B 62.38M 421M 164M 2.12B 166M 162M 7.04B |
| Net Debt | - | - |
Employees
7,048
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/08/26 | €4.780 | +1.70% | 0 |
| 13/08/26 | €4.700 | 0.00% | 30,020 |
| 12/08/26 | €4.700 | +2.62% | 3,664 |
| 11/08/26 | €4.580 | +0.44% | 439 |
| 10/08/26 | €4.560 | +6.05% | 42,209 |
Sell
Buy

Mean consensus
BUY
Number of Analysts
1
Last Close Price
4.700EUR
Average target price
7.300EUR
Spread / Average Target
+55.32%
Net sales - Rate of surprise
- Stock Market
- Stocks
- MED Stock
Select your edition
All financial news and data tailored to specific country editions
















